Shimura Tatsuo, Suehiro Taketoshi, Suzuki Hideki, Mochida Yasushi, Okada Koji, Araki Kenichiro, Kuwano Hiroyuki
Department of General Surgical Science (Surgery I), Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan.
Am J Surg. 2007 Oct;194(4):553-5. doi: 10.1016/j.amjsurg.2006.11.043.
Pancreatic fistula is a major problem in minimal invasive surgery of the pancreas. To prevent the disruption of the pancreatic duct, the surgeon must recognize the site of the pancreatic duct exactly.
We reviewed the cases of 7 patients who underwent preoperative endoscopic pancreatic stenting for the prophylaxis of pancreatic fistula development after enucleation of a benign pancreatic head tumor.
Preoperative endoscopic pancreatic stenting was successfully performed in all 7 patients. The level of serum amylase increased to 1500 IU/L on postoperative day 1, but levels recovered to normal within 3 days. None of the patients developed a pancreatic fistula.
Preoperative pancreatic duct stenting is a feasible, effective, and safe technique to prevent pancreatic duct disruption during enucleation of a benign tumor of the pancreatic head.
胰瘘是胰腺微创手术中的一个主要问题。为防止胰管破裂,外科医生必须准确识别胰管的位置。
我们回顾了7例因预防良性胰头部肿瘤摘除术后胰瘘形成而接受术前内镜下胰管支架置入术的患者病例。
所有7例患者均成功进行了术前内镜下胰管支架置入术。术后第1天血清淀粉酶水平升至1500 IU/L,但3天内恢复正常。所有患者均未发生胰瘘。
术前胰管支架置入术是一种在良性胰头部肿瘤摘除术中预防胰管破裂的可行、有效且安全的技术。